# Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

> **NCT00002917** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mary Babb Randolph Cancer Center at West Virginia University Hospitals**

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00002917
- **Lead sponsor:** Mary Babb Randolph Cancer Center at West Virginia University Hospitals
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-11
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002917, "Paclitaxel in Treating Patients With Early-Stage Bladder Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*